- Home
- CSTL vs BITF Comparison
CSTL vs BITF Comparison
Compare CSTL & BITF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSTL
- BITF
- Stock Information
- Founded
- CSTL 2007
- BITF 2017
- Country
- CSTL United States
- BITF Canada
- Employees
- CSTL N/A
- BITF N/A
- Industry
- CSTL Medical Specialities
- BITF Finance: Consumer Services
- Sector
- CSTL Health Care
- BITF Finance
- Exchange
- CSTL Nasdaq
- BITF Nasdaq
- Market Cap
- CSTL 561.9M
- BITF 564.7M
- IPO Year
- CSTL 2019
- BITF N/A
- Fundamental
- Price
- CSTL $16.53
- BITF $1.05
- Analyst Decision
- CSTL Strong Buy
- BITF Strong Buy
- Analyst Count
- CSTL 6
- BITF 3
- Target Price
- CSTL $37.67
- BITF $4.83
- AVG Volume (30 Days)
- CSTL 396.8K
- BITF 19.5M
- Earning Date
- CSTL 08-04-2025
- BITF 08-07-2025
- Dividend Yield
- CSTL N/A
- BITF N/A
- EPS Growth
- CSTL N/A
- BITF N/A
- EPS
- CSTL N/A
- BITF N/A
- Revenue
- CSTL $347,083,000.00
- BITF $209,412,000.00
- Revenue This Year
- CSTL N/A
- BITF $88.01
- Revenue Next Year
- CSTL $1.36
- BITF $84.80
- P/E Ratio
- CSTL N/A
- BITF N/A
- Revenue Growth
- CSTL 38.43
- BITF 25.67
- 52 Week Low
- CSTL $15.45
- BITF $0.67
- 52 Week High
- CSTL $35.84
- BITF $3.06
- Technical
- Relative Strength Index (RSI)
- CSTL 34.83
- BITF 65.74
- Support Level
- CSTL $19.29
- BITF $1.01
- Resistance Level
- CSTL $20.26
- BITF $1.16
- Average True Range (ATR)
- CSTL 0.70
- BITF 0.08
- MACD
- CSTL -0.35
- BITF 0.02
- Stochastic Oscillator
- CSTL 4.44
- BITF 86.25
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.
About BITF Bitfarms Ltd.
Bitfarms Ltd engaged in the cryptocurrency Mining industry mainly consists of selling its computational power used for hashing calculations for cryptocurrency mining in multiple jurisdictions. Its geographic operations are currently located in Canada, the United States, Argentina. It owns and operates server farms comprised of computers designed to validate transactions on the Bitcoin Blockchain.